| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Apr 26, 2021 | Apr 28, 2021 | Lee Kevin CEO | Sell | $31.13 | $785,873 | -9.02% |
| Apr 08, 2021 | Apr 09, 2021 | Legault Pierre Dir | Sell | $31.71 | $787,588 | -0 |
| Apr 05, 2021 | Apr 07, 2021 | Legault Pierre Dir | Sell | $31.07 | $5,033 | -0 |
| Mar 31, 2021 | Apr 02, 2021 | Keen Nicholas Chief Scientific Officer | Sell | $30 | $300,000 | -26.10% |
| Mar 31, 2021 | Apr 02, 2021 | Legault Pierre Dir | Sell | $30 | $300,000 | -0 |
| Mar 17, 2021 | Mar 19, 2021 | Legault Pierre Dir | Sell | $29 | $225,736 | -0 |
| Mar 12, 2021 | Mar 16, 2021 | Legault Pierre Dir | Sell | $29 | $64,264 | -0 |
| Mar 12, 2021 | Mar 16, 2021 | Keen Nicholas Chief Scientific Officer | Sell | $28.48 | $284,843 | -20.69% |
| Feb 05, 2021 | Feb 09, 2021 | Lee Kevin CEO | Sell | $31 | $3,100 | -0.04% |
| Jan 19, 2021 | Jan 21, 2021 | Lee Kevin CEO | Sell | $29.76 | $184,070 | -2.33% |
| Jan 19, 2021 | Jan 21, 2021 | Kalowski Lee Pres CFO | Sell | $30 | $450,000 | -0 |
| Jan 14, 2021 | Jan 15, 2021 | Kalowski Lee Pres CFO | Sell | $25 | $250,000 | -0 |
| Jan 14, 2021 | Jan 15, 2021 | Lee Kevin CEO | Sell | $26.01 | $260,050 | -3.64% |
| Dec 01, 2020 | Dec 04, 2020 | Kalowski Lee Pres CFO | Sell | $22.5 | $168,750 | -0 |
| Nov 27, 2020 | Nov 30, 2020 | Kalowski Lee Pres CFO | Sell | $20 | $10,600 | -0 |
| Nov 23, 2020 | Nov 26, 2020 | Kalowski Lee Pres CFO | Sell | $19.92 | $537,110 | -0 |
| Jul 14, 2020 | Sep 18, 2020 | Glaxosmithkline Plc 10% | Sell | $19.36 | $91,826 | -0.25% |
| May 28, 2019 | Jun 03, 2019 | Tybourne Capital Management (Hk) Ltd 10% | Buy | $14 | $5M | +15.69% |
| May 29, 2019 | May 31, 2019 | Cambridge Innovation Capital (Jersey) Ltd 10% | Buy | $14 | $4M | +15.21% |
| May 28, 2019 | May 31, 2019 | Novartis Bioventures Ltd 10% | Buy | $14 | $2M | +8.70% |
| May 27, 2019 | May 31, 2019 | Ng Carolyn Dir | Buy | $14 | $8M | +20.67% |
| May 28, 2019 | May 31, 2019 | Svlsf V, LLC 10% | Buy | $14 | $5M | +16.76% |
| May 28, 2019 | May 31, 2019 | Anstey Michael Dir | Buy | $14 | $4M | +15.21% |
| May 28, 2019 | May 31, 2019 | Bingham Kate Dir | Buy | $14 | $5M | +16.76% |
| May 28, 2019 | May 31, 2019 | Harland Deborah Dir | Buy | $14 | $5M | +16.76% |
| May 28, 2019 | May 30, 2019 | Glaxosmithkline Plc Dir 10% | Buy | $14 | $5M | +16.76% |